Is a Breakup Allergan’s Best Bet?
October 18, 2017 at 10:10 AM EDT
In the aftermath of a devastating patent ruling, one analyst asked Allergan CEO Brent Saunders about a breakup of the drug maker. Saunders says that discussion is "premature."
